CUA Educational Content

CUA Practice Changing Publications (PCP): TESTIS CANCER

EDITORIAL COMMITTEE: Armen Aprikian and Rob Hamilton

By the end of this presentation, participants will be able to:

  • Understand the latest data on adjuvant BEP x 1 for stage I NSGCT
  • Recognize the current literature regarding the pros and cons of robotic RPLND
  • Understand the choices of adjuvant chemotherapy after primary RPLND
  • Know the outcomes of surveillance after complete response after chemotherapy in patients with metastatic NSGCT
  • Understand the importance of long-term mental health and survivorship issues, in men with testicular cancer
  • Know the future potential of miRNA as a biomarker and the role of RPLND in seminoma


This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1 hour of credit.